Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Season 2, Episode 16: Breaking Barriers with Jacob Becraft
Join Michael Pietrack on the Pharmaverse Podcast as he interviews Jake Becraft, CEO & Co-founder of Strand Therapeutics! Discover how Jake is transforming cancer treatment with programmable mRNA therapies.
Hear about his journey from a small town in Illinois to MIT, how jiu-jitsu shaped his leadership, and the lessons of team-building, failure, and innovation. Learn about Strand’s breakthroughs, including the game-changing abscopal response, and the mindset needed to challenge scientific dogma.
Related Topics
You May Also Like
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Article
Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer
Value assessment of oncology drugs using a weighted criterion-based approach
Article
Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD
Outcome measures for oncology alternative payment models: practical considerations and recommendations
Article
Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
Article
M. Bertagnolli and J. Tabernero
Value assessment frameworks in oncology: championing concordance through shared standards
Article
E.M. Ray, L.A. Carey, K.E. Reeder-Hayes